Power3, Biosite to Develop Protein Biomarker-based Diagnostics | GenomeWeb

NEW YORK, July 12 (GenomeWeb News) - Proteomic tool shop Power3 Medical Products will give Biosite access to certain of its protein biomarker antibody targets and intellectual property as part of an alliance to evaluate and develop diagnostic tests, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.